These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1110 related articles for article (PubMed ID: 6480287)

  • 21. [Effects of platelet aggregating inhibitor on pulmonary metastases of tumor cells after surgical resection].
    Yano S
    Hokkaido Igaku Zasshi; 1993 Sep; 68(5):654-63. PubMed ID: 8225173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of antiplatelet agents on pulmonary metastases.
    Bando H; Yamashita T; Tsubura E
    Gan; 1984 Mar; 75(3):284-91. PubMed ID: 6724229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between cellular procoagulant activity and metastatic capacity of B16 mouse melanoma variants.
    Gilbert LC; Gordon SG
    Cancer Res; 1983 Feb; 43(2):536-40. PubMed ID: 6848176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ticlopidine on metastasis production in mice bearing Lewis lung carcinoma.
    Fabra A; de Castellarnau C; Carretero F; Martínez E; Sancho MJ; Rutllant ML
    Invasion Metastasis; 1987; 7(1):53-60. PubMed ID: 3583621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation.
    Viisoreanu D; Gear A
    Thromb Res; 2007; 120(6):885-92. PubMed ID: 17306868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibition of metastasis by anti-platelet agents-prostaglandins].
    Niitsu Y; Urushizaki I
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1228-34. PubMed ID: 3890759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
    Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y
    Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro effect of culture fluids from neoplastic tissues on platelet aggregation. II. Experimental tumors].
    Pacchiarini L; Serra L; Grignani G; Gamba G; Gorini M
    Boll Soc Ital Biol Sper; 1982 Jul; 58(13):854-9. PubMed ID: 7126359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of hematocrit on adenosine diphosphate-induced aggregation of human platelets in tube flow.
    Goldsmith HL; Kaufer ES; McIntosh FA
    Biorheology; 1995; 32(5):537-52. PubMed ID: 8541523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of amino sugars on platelet aggregation and on fibrinogen binding.
    Kinlough-Rathbone RL; Packham MA; Mustard JF
    Thromb Haemost; 1984 Aug; 52(1):75-80. PubMed ID: 6495268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of ADP-induced aggregation by 5-HT in rabbit platelets.
    Li BY; Bai Y; Li WH
    Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):58-62. PubMed ID: 10375761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet aggregation and adenosine diphosphate/adenosine triphosphate receptors: a historical perspective.
    Packham MA; Mustard JF
    Semin Thromb Hemost; 2005 Apr; 31(2):129-38. PubMed ID: 15852216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of phosphodiesterase inhibitors on platelet aggregation and tumor metastasis.
    Ambrus JL; Ambrus CM; Gastpar H
    Ric Clin Lab; 1981; 11 Suppl 1():197-207. PubMed ID: 6324323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-released ADP stabilizes PAF-induced rabbit platelet aggregation by stabilizing intracellular calcium.
    Yi FX; Guo ZG
    Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):379-82. PubMed ID: 10375790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombin-induced neuropeptide Y secretion from rat platelets.
    Chen SH; Han QD
    Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):360-5. PubMed ID: 7668111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of cordycepin on hematogenic metastasis of B16-F1 mouse melanoma cells accelerated by adenosine-5'-diphosphate.
    Yoshikawa N; Kunitomo M; Kagota S; Shinozuka K; Nakamura K
    Anticancer Res; 2009 Oct; 29(10):3857-60. PubMed ID: 19846919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of tissue factor in two human pancreatic cancer cell lines.
    Silberberg JM; Gordon S; Zucker S
    Cancer Res; 1989 Oct; 49(19):5443-7. PubMed ID: 2548721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.